COST-UTILITY ANALYSIS PATIENTS WITH LOW BACK PAIN AFTER TREATMENT INTRAOSSEOUS BLOCKADES

• Main Authors: M. V. Yakovlev (Author), A. U. Kulikov (Author), E. L. Sokov (Author), I. E. Kornilova (Author)
• Format: Book
• Published: IRBIS LLC, 2015-03-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.
• Notes: 2070-4909; 2070-4933
• Keywords: pharmacoeconomics; quality of life; qaly; cost-utility analysis; intraosseous blockades; low back pain; Therapeutics. Pharmacology; RM1-950; Economics as a science; HB71-74
• Source: Фармакоэкономика, Vol 5, Iss 3, Pp 13-19 (2015)

a total of 62 patients with a diagnosis of low back pain. Low back pain patients were randomized of two group. Patients of the first (main) group received a course of intraosseous blockades, while patients of the second (control group) received a course of conservatively treatment (analgetics, NSAIDs, myorelaxants, physical therapy). Measured direct costs at 1-year follow-up. Quality of life was measured with the Oswestry low back pain disability questionnaire, converted into utilities and transformed into quality-adjusted life years - QALY. The analysis will be performed for the health systems. Mean QALY in the first group was 0,358 and 0,134 in the second group.The cost-utility ratio for first group was 39 090,5 RUB for 1 QALY, and for standard therapy it was 179 552,2 RUB for 1 QALY. Treatment by intraosseous blockades is dominant alternative.